Racz A, Veresh Z, Erdei N, Bagi Z, Koller A
Department of Pathophysiology, Semmelweis University, Budapest, Hungary.
J Vasc Res. 2009;46(5):397-405. doi: 10.1159/000194270. Epub 2009 Jan 21.
It has been shown that increases in intraluminal flow elicit dilation in venules, but the mediation of response is not yet clarified. We hypothesized that - in addition to nitric oxide (NO) and dilator prostaglandins (PGI(2)/ PGE(2)) - thromboxane A(2) (TxA(2)) contributes to the mediation of flow-induced responses of venules.
Isolated rat gracilis muscle venules (259 +/- 11 microm at 10 mm Hg) dilated as a function of intraluminal flow, which was augmented in the presence of the TxA(2) receptor antagonist SQ 29,548 or the TxA(2) synthase inhibitor ozagrel. In the presence of SQ 29,548, indomethacin or Nomega-nitro-L-arginine methyl-ester decreased flow-induced dilations, whereas in their simultaneous presence dilations were abolished. The selective cyclooxygenase (COX) 1 inhibitor SC 560 reduced, whereas the selective COX-2 inhibitor NS 398 enhanced flow-induced dilations. Immunohistochemistry showed that both COX-1 and COX-2 are present in the wall of venules.
In skeletal muscle venules, increases in intraluminal flow elicit production of constrictor TxA(2), in addition to the dilator NO and PGI(2)/PGE(2), with an overall effect of limited dilation. These mediators are likely to have important roles in the multiple feedback regulation of wall shear stress in venules during changes in blood flow velocity and/or viscosity.
研究表明,管腔内血流增加会引起微静脉扩张,但其反应的介导机制尚不清楚。我们推测,除一氧化氮(NO)和扩张性前列腺素(前列环素I2/前列腺素E2)外,血栓素A2(TxA2)也参与介导微静脉的血流诱导反应。
分离的大鼠股薄肌微静脉(在10 mmHg时直径为259±11微米)随着管腔内血流的增加而扩张,在存在TxA2受体拮抗剂SQ 29548或TxA2合酶抑制剂奥扎格雷的情况下,这种扩张会增强。在存在SQ 29548的情况下,吲哚美辛或Nω-硝基-L-精氨酸甲酯会降低血流诱导的扩张,而当它们同时存在时,扩张则被消除。选择性环氧化酶(COX)1抑制剂SC 560会降低,而选择性COX-2抑制剂NS 398会增强血流诱导的扩张。免疫组织化学显示,COX-1和COX-2均存在于微静脉壁中。
在骨骼肌微静脉中,管腔内血流增加除了会引起扩张性的NO和前列环素I2/前列腺素E2生成外,还会引起收缩性TxA2的生成,总体效果是有限的扩张。这些介质可能在血流速度和/或粘度变化期间微静脉壁剪切应力的多重反馈调节中发挥重要作用。